These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12960827)

  • 41. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models.
    Boily MC; Bastos FI; Desai K; Mâsse B
    Sex Transm Dis; 2004 Feb; 31(2):100-13. PubMed ID: 14743073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of orphanhood before and after implementation of a HIV care programme in Rakai, Uganda: Alpha Network HIV Supplement.
    Makumbi FE; Nakigozi G; Sekasanvu J; Lukabwe I; Kagaayi J; Lutalo T; Wawer M; Gray R
    Trop Med Int Health; 2012 Aug; 17(8):e94-102. PubMed ID: 22716203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
    Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
    Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates.
    Robinson NJ; Mulder DW; Auvert B; Hayes RJ
    Int J Epidemiol; 1997 Feb; 26(1):180-9. PubMed ID: 9126519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence rate of sexually transmitted infections among HIV infected patients on long-term ART in an urban and a rural clinic in Uganda.
    Okoboi S; Castelnuovo B; Moore DM; Musaazi J; Kambugu A; Birungi J; Nanfuka M; Van Rie A
    BMC Public Health; 2019 Jan; 19(1):87. PubMed ID: 30658611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.
    Solomon SS; Mehta SH; McFall AM; Srikrishnan AK; Saravanan S; Laeyendecker O; Balakrishnan P; Celentano DD; Solomon S; Lucas GM
    Lancet HIV; 2016 Apr; 3(4):e183-90. PubMed ID: 27036994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics.
    Owens DK; Edwards DM; Shachter RD
    AIDS; 1998 Jun; 12(9):1057-66. PubMed ID: 9662203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV prevalence and uptake of HIV/AIDS services among youths (15-24 Years) in fishing and neighboring communities of Kasensero, Rakai District, South Western Uganda.
    Mafigiri R; Matovu JK; Makumbi FE; Ndyanabo A; Nabukalu D; Sakor M; Kigozi G; Nalugoda F; Wanyenze RK
    BMC Public Health; 2017 Mar; 17(1):251. PubMed ID: 28288604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marriage and the risk of incident HIV infection in Rakai, Uganda.
    Nalugoda F; Guwatudde D; Bwaninka JB; Makumbi FE; Lutalo T; Kagaayi J; Sewankambo NK; Kigozi G; Serwadda DM; Kong X; Wawer MJ; Wabwire-Mangen F; Gray RH
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):91-8. PubMed ID: 24419066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.
    Quinn TC; Wawer MJ; Sewankambo N; Serwadda D; Li C; Wabwire-Mangen F; Meehan MO; Lutalo T; Gray RH
    N Engl J Med; 2000 Mar; 342(13):921-9. PubMed ID: 10738050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complementary hypothesis concerning the community sexually transmitted disease mass treatment puzzle in Rakai, Uganda.
    Boily MC; Lowndes CM; Alary M
    AIDS; 2000 Nov; 14(16):2583-92. PubMed ID: 11101071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.
    Ying R; Sharma M; Heffron R; Celum CL; Baeten JM; Katabira E; Bulya N; Barnabas RV
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20013. PubMed ID: 26198348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda.
    Were WA; Mermin JH; Wamai N; Awor AC; Bechange S; Moss S; Solberg P; Downing RG; Coutinho A; Bunnell RE
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):91-5. PubMed ID: 16885775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
    Wawer MJ; Gray RH; Sewankambo NK; Serwadda D; Li X; Laeyendecker O; Kiwanuka N; Kigozi G; Kiddugavu M; Lutalo T; Nalugoda F; Wabwire-Mangen F; Meehan MP; Quinn TC
    J Infect Dis; 2005 May; 191(9):1403-9. PubMed ID: 15809897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study.
    Tobian AA; Kigozi G; Manucci J; Grabowski MK; Serwadda D; Musoke R; Redd AD; Nalugoda F; Reynolds SJ; Kighoma N; Laeyendecker O; Lessler J; Gray RH; Quinn TC; Wawer MJ;
    PLoS Med; 2015 Apr; 12(4):e1001820. PubMed ID: 25919012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through the Drug Resource Enhancement Against AIDS and Malnutrition model: antiretrovirals for 5 reduction of population infectivity, incidence and prevalence at the district level.
    Palombi L; Bernava GM; Nucita A; Giglio P; Liotta G; Nielsen-Saines K; Orlando S; Mancinelli S; Buonomo E; Scarcella P; Altan AM; Guidotti G; Ceffa S; Haswell J; Zimba I; Magid NA; Marazzi MC
    Clin Infect Dis; 2012 Jul; 55(2):268-75. PubMed ID: 22491503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sexual behavior, risk perception, and HIV transmission can respond to HIV antiviral drugs and vaccines through multiple pathways.
    Tully S; Cojocaru M; Bauch CT
    Sci Rep; 2015 Oct; 5():15411. PubMed ID: 26507957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus.
    Davenport MP; Ribeiro RM; Chao DL; Perelson AS
    J Virol; 2004 Oct; 78(20):11340-51. PubMed ID: 15452255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
    Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.